DUBLIN--(BUSINESS WIRE)--The "Latent TB Diagnostics Market 2025-2029 - Global Market Analysis and Forecasts by Assay, Risk Factor, and Lab/Place, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering.
This comprehensive report unveils the emerging leaders in the TB diagnostics field and highlights the most lucrative segments ripe for investment. The research provides detailed forecasts of market size over the next five years, empowering stakeholders to anticipate shifts and strategize effectively. Early disruptors in the diagnostic space are positioning themselves to challenge traditional players, potentially reshaping the competitive landscape.
Latent TB Diagnostics has traditionally been dominated by a small number of established companies offering a standard commodity product. However, the landscape is evolving with the emergence of new technologies and niche markets reshaping this sector. The tuberculosis diagnostics market is expanding rapidly, particularly in certain segments where the growth trajectory is notably steep. This transformation is driven by innovative diagnostic technologies and shifting market dynamics that are redefining competitive strategies.
By delving into this research, professionals can gain unparalleled insights into the complexities and future directions of the TB diagnostics market. The report covers a breadth of topics, from technological advancements and market entry strategies to investment opportunities and competitive analysis. It equips decision-makers with the critical information necessary to navigate this evolving market confidently.
The report not only positions you as a subject matter expert within your organization but also offers ongoing support and access to supplementary data at no additional cost. This ensures you stay informed about the latest developments and have access to tailored data to support strategic decision-making and business growth.
Whether you're contemplating new investments or seeking to enhance your market position, this report provides the foundational data and insights required to make informed decisions. Embrace the future of TB diagnostics with confidence, armed with the latest market insights and forecasts.
Key Topics Covered:
1 Market Guides
1.1 Situation Analysis
1.2 Guide for Executives and Marketing Staff
1.3 Guide for Investment Analysts and Management Consultants
2 Introduction and Market Definition
2.1 An Overview of TB Diagnostics
2.2 Market Definition
2.3 Methodology
2.4 Healthcare and the IVD Industry
3 Tuberculosis - Current Science
3.1 What is Tuberculosis?
3.2 Diagnosis
3.3 Prevalence
4 Industry Overview
4.1 Players in a Dynamic Market
5 Market Trends
5.1 Factors Driving Growth
5.2 Factors Limiting Growth
5.3 Diagnostic Technology Development
6 TB Diagnostics - Recent Developments
6.1 Recent Developments - Importance and How to Use This Section
6.2 Danaher, Cepheid Urged to Further Reduce Price of TB Tests
6.3 Co-Diagnostics Submits At-Home PCR System
6.4 Innovation in TB research by Nanopore
6.5 New skin test for latent TB diagnostics
6.6 Latent TB Infection Screening Recommended
6.7 QIAGEN's QuantiFERON-TB Gold Plus gains new CE-marking
6.8 PerkinElmer Hopes to Gain Market Share against Qiagen
6.9 PBD Biotech to Develop TB Blood Test
6.10 WHO Expands Assessment for TB MDx Developers
6.11 Cepheid Omni POC System Falls Off Radar
6.12 Non-Sputum CRISPR-Based TB Test Shows High Sensitivity
6.13 NGeneBio Gets CE Mark for NGS-Based TB Assay
6.14 MDx TB Assay From PBD Biotech Shows Promise
6.15 Minute Molecular Dx to Launch Rapid PCR Test
6.16 Qiagen Next-Gen TB Test Gains Chinese Approval
6.17 FIND Invests $21M to Launch POC MDx Platforms
6.18 Qiagen, DiaSorin Obtain FDA Approval for Latent TB Test
6.19 Oxford Immunotec to Automate Latent TB Test
6.20 LumiraDx Eyes Test Menu Expansion
6.21 BioMerieux Targeting Hospitals With Desktop Latent TB Test
7 Profiles of Key Companies
7.1 AID GmbH
7.2 Beijing Wantai
7.3 bioMerieux Diagnostics
7.4 Boditech Med, Inc
7.5 Endo International
7.6 Erythra
7.7 Generium
7.8 Glory Biotechnologies Corp.
7.9 Lionex Diagnostics & Therapeutics GmbH
7.10 Oxford Immunotec (Perkin Elmer)
7.11 Perkin Elmer
7.12 Qiagen
7.13 R-Biopharm AG
7.14 Sanofi
7.15 SD Biosensor
7.16 Serum Institute of India
7.17 Statens Serum Institut
7.18 Zhifei Longcom
8 Latent TB Global Diagnostic Markets Overview
8.1 Latent TB Diagnostics - Global Market Overview by Country
8.2 Global Latent TB Diagnostics Markets Overview by Assay
8.3 Global Latent TB Diagnostics Markets Overview by Risk Factor
8.4 Global Latent TB Diagnostics Markets Overview by Lab
9 Latent TB Diagnostic Market - by Assay
9.1 Latent TB Diagnostic - TST
9.2 Latent TB Diagnostic - IGRA
9.3 Latent TB Diagnostic - TBST
9.4 Latent TB Diagnostic -Other
10 Global Latent TB Diagnostics Markets - By Risk Factor
10.1 Latent TB Diagnostic - HIV
10.2 Latent TB Diagnostic - Pediatric
10.3 Latent TB Diagnostic - Diabetes
10.4 Latent TB Diagnostic - Immigration
10.5 Latent TB Diagnostic - Other Risk Factor
11 Global Latent TB Diagnostics Markets - By Lab/Place
11.1 Latent TB Diagnostic - Hospital Lab
11.2 Latent TB Diagnostic - Outpatient Lab
11.3 Latent TB Diagnostic - Point of Care
11.4 Latent TB Diagnostic - Other Place
12 Appendices
12.1 United States Medicare System: Clinical Laboratory Fees Schedule
For more information about this report visit https://www.researchandmarkets.com/r/xtwjja
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
